Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
HAKI Safety A | HAKIA | Sep 27, 2024 | 26.20 | +0.77 |
HAKI Safety B | HAKIB | Sep 27, 2024 | 25.60 | -0.39 |
Hamlet BioPharma AB (publ) | HAMLETB | Sep 27, 2024 | 4.00 | -0.74 |
Hansa Biopharma | HNSA | Sep 27, 2024 | 40.76 | +2.77 |
Hanza AB | HANZA | Sep 27, 2024 | 54.00 | +1.69 |
Harm Reduction Group | NOHARM | Sep 27, 2024 | 0.07 | -1.62 |
Havsfrun Investment | HAVS | Sep 27, 2024 | 10.90 | -0.91 |
Havsfrun Investment B | HAVB | Sep 27, 2024 | 10.90 | -0.91 |
Haypp Group | HAYPP | Sep 27, 2024 | 82.60 | 0.00 |
Headsent | VIMAB | Sep 27, 2024 | 7.40 | -0.67 |
Heba B | HEBAB | Sep 27, 2024 | 36.45 | +1.53 |
Hedera Group | HEGR | Sep 27, 2024 | 3.60 | -3.23 |
Heimstaden Pref | HEIMPREF | Sep 27, 2024 | 17.14 | +1.18 |
Heliospectra | HELIO | Sep 27, 2024 | 0.49 | -3.89 |
Hemnet Group | HEM | Sep 27, 2024 | 369.60 | -0.65 |
Hemply Balance | HMPLY | Sep 27, 2024 | 0.05 | +1.92 |
Hernö Gin B | HERNOB | Sep 27, 2024 | 4.38 | -6.01 |
Hexagon B | HEXAB | Sep 27, 2024 | 110.55 | +2.46 |
Hexagon Purus | HPURO | Sep 27, 2024 | 10.82 | +8.74 |
Hexatronic Group | HTRO | Sep 27, 2024 | 51.94 | -1.07 |
Hexicon | HEXI | Sep 27, 2024 | 0.25 | -2.12 |
Hexpol B | HPOLB | Sep 27, 2024 | 108.00 | 0.00 |
Hifab B | HIFAB | Sep 27, 2024 | 3.22 | +2.55 |
High Coast Distillery B | HIGHCOB | Sep 27, 2024 | 40.00 | -2.44 |
Hilbert | HILBB | Sep 27, 2024 | 4.99 | -3.67 |
HMS Networks | HMS | Sep 27, 2024 | 407.40 | -0.44 |
Hoegh Autoliners ASA | HAUTOO | Sep 27, 2024 | 140.30 | -1.75 |
Hoi Publishing AB | HOIB | Sep 27, 2024 | 0.32 | +1.27 |
Hoist Finance | HOFI | Sep 27, 2024 | 89.90 | -1.10 |
Holmen A | HOLMA | Sep 27, 2024 | 437.00 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.